A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly's weight loss and diabetes drugs Zepbound and Mounjaro. In a sealed decision filed ...
Pharmalittle: We’re reading about Zepbound price and dose changes, compounders suing FDA, and more
Rise and shine, everyone, another busy day is on the way. We can tell by the speed at which the notes are arriving through the various communications channels on our laptop and phone, and by the ...
The FDA’s declaration set a deadline for compounders to stop offering their versions of semaglutide — April 22 or May 22, depending on which type of legal authorization they have to sell the drug. In ...
Generation Z, or those born between 1997 and 2012, are shaping the travel landscape with their unique and fresh take on what fuels them to explore the world, one country at a time. In a January 2025 ...
Compound Protocol COMP/USD is pointing north again after the latest slump. The gains in the past week are more than 12%, helping the token move above the 50-day MA. The price surge indicates COMP’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback